创伤特异性修订的日本急诊医学会弥散性血管内凝血标准可改善严重创伤患者的结局预测
本研究为多中心回顾性队列研究,纳入 2018 年 4 月 1 日至 2019 年 3 月 31 日期间 18 岁及以上、损伤严重度评分≥16 的严重创伤患者 719 例,主要终点为全因住院死亡。研究通过 ROC 曲线确定传统日本急诊医学会 DIC 各变量预测全因住院死亡的最优 cutoff 值:凝血酶原时间国际标准化比值 1.080、纤维蛋白降解产物 116.0 μg/mL、血小板计数 17.0(×10⁴/μL),并据此构建创伤特异性 DIC 评分。DIC 组全因死亡率高于非 DIC 组;新创伤 DIC 评分在预测全因死亡、24 小时死亡、创伤性脑损伤所致死亡和大量输血需求方面优于传统评分,但在预测失血性死亡方面两者表现相似。作者结论认为该评分在创伤人群中具有前景,但需在不同临床环境中进行外部验证。
要点
- 在 719 例损伤严重度评分≥16 的严重创伤患者中,DIC 组全因死亡率高于非 DIC 组。
- 预测全因住院死亡的最优 cutoff 值为:凝血酶原时间国际标准化比值 1.080、纤维蛋白降解产物 116.0 μg/mL、血小板计数 17.0(×10⁴/μL)。
- 新创伤 DIC 评分在预测全因死亡、24 小时死亡、创伤性脑损伤所致死亡和大量输血需求方面优于传统评分。
- 在预测失血性死亡方面,新创伤 DIC 评分与传统评分表现相似。
- 作者结论认为该评分在创伤人群中具有前景,但需在不同临床环境中进行外部验证。
适用人群与场景
- 18 岁及以上、损伤严重度评分≥16 的严重创伤患者。
- 数据来自 2018 年 4 月 1 日至 2019 年 3 月 31 日的多中心创伤队列。
诊断标准与关键阈值
- 传统日本急诊医学会 DIC 标准各变量预测全因住院死亡的最优 cutoff 值:凝血酶原时间国际标准化比值 1.080、纤维蛋白降解产物 116.0 μg/mL、血小板计数 17.0(×10⁴/μL)。
研究设计与关键结果
- 研究类型为多中心回顾性队列研究,纳入 719 例损伤严重度评分≥16 的严重创伤患者,主要终点为全因住院死亡,次要终点为 24 小时死亡、病因特异性住院死亡(失血、创伤性脑损伤及其他)和大量输血发生率。
- DIC 组全因死亡率高于非 DIC 组。
- 新创伤 DIC 评分在预测全因死亡、24 小时死亡、创伤性脑损伤所致死亡和大量输血需求方面优于传统评分;在预测失血性死亡方面两者表现相似。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究,证据等级为 Level IV。
- 局限:原文报告需在不同临床环境中进行外部验证。
对床旁实践的改变
- 作者结论认为,该创伤特异性 DIC 评分在严重创伤人群中预测临床结局方面具有前景,但需在不同临床环境中进行外部验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: No universal definition of trauma-induced coagulopathy exists, and no validated scoring system accurately evaluates coagulopathy in patients with severe trauma. Although developed for sepsis and other critical illnesses, the conventional Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) score's applicability to trauma populations remains controversial. This study aimed to evaluate the JAAM DIC score's diagnostic performance in patients with severe trauma and develop a trauma-specific coagulopathy scoring system based on its original components.
METHODS: This retrospective study analyzed data from a multicenter trauma cohort between April 1, 2018, and March 31, 2019. Patients 18 years or older with severe trauma and an Injury Severity Score of ≥16 were included. The primary outcome was defined as all-cause in-hospital mortality. The secondary outcomes were 24-hour mortality, cause-specific in-hospital mortality (exsanguination, traumatic brain injury [TBI], and others), and massive transfusion incidence. The conventional JAAM DIC variables' predictive performance for all-cause in-hospital mortality, 24-hour mortality, death due to exsanguination, TBI-induced death, and massive transfusion occurrence were assessed using receiver operating characteristic curves. A new trauma DIC score was developed using the optimal cutoff values and compared with the conventional scores.
RESULTS: Among 719 patients analyzed, optimal cutoff values for predicting in-hospital mortality were a prothrombin time-international normalized ratio of 1.080, fibrin degradation products of 116.0 μg/mL, and platelet count of 17.0 (×10 4 /μL). The DIC group had higher all-cause mortality rates than the non-DIC group. The new trauma DIC score outperformed the conventional score for predicting all-cause mortality, 24-hour mortality, TBI-induced death, and massive transfusion requirements; however, both performed similarly for exsanguination-induced death.
CONCLUSION: We developed a trauma-specific DIC score that outperformed the conventional score for predicting clinical outcomes in patients with severe trauma. While promising for trauma populations, external validation in various clinical settings is warranted. ( J Trauma Acute Care Surg. 2026;101: 121-128. © 2026 The Author (s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Surgery of Trauma.).
LEVEL OF EVIDENCE: Multicenter Retrospective Cohort Study; Level IV.
参考来源
- Sugimoto M, Takayama W, Wada T, et al. Trauma-specific revision of the Japanese Association for Acute Medicine disseminated intravascular coagulation criteria improves outcome prediction in severely injured patients. J Trauma Acute Care Surg. 2026. PMID: 41636725. doi:10.1097/TA.0000000000004914
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。